604 related articles for article (PubMed ID: 19579220)
1. Molecular facets of sphingolipids: mediators of diseases.
Ozbayraktar FB; Ulgen KO
Biotechnol J; 2009 Jul; 4(7):1028-41. PubMed ID: 19579220
[TBL] [Abstract][Full Text] [Related]
2. Organization and functions of sphingolipid biosynthesis in yeast.
Riezman H
Biochem Soc Trans; 2006 Jun; 34(Pt 3):367-9. PubMed ID: 16709163
[TBL] [Abstract][Full Text] [Related]
3. Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiology.
Merrill AH; Schmelz EM; Dillehay DL; Spiegel S; Shayman JA; Schroeder JJ; Riley RT; Voss KA; Wang E
Toxicol Appl Pharmacol; 1997 Jan; 142(1):208-25. PubMed ID: 9007051
[TBL] [Abstract][Full Text] [Related]
4. Sphingolipid signalling and liver diseases.
Marà M; Fernández-Checa JC
Liver Int; 2007 May; 27(4):440-50. PubMed ID: 17403183
[TBL] [Abstract][Full Text] [Related]
5. Sphingolipids: major regulators of lipid metabolism.
Worgall TS
Curr Opin Clin Nutr Metab Care; 2007 Mar; 10(2):149-55. PubMed ID: 17285002
[TBL] [Abstract][Full Text] [Related]
6. The biochemistry of sphingolipid storage diseases.
Sandhoff K
Angew Chem Int Ed Engl; 1977 May; 16(5):273-85. PubMed ID: 406814
[No Abstract] [Full Text] [Related]
7. Functions and metabolism of sphingolipids in Saccharomyces cerevisiae.
Dickson RC; Sumanasekera C; Lester RL
Prog Lipid Res; 2006 Nov; 45(6):447-65. PubMed ID: 16730802
[TBL] [Abstract][Full Text] [Related]
8. Translational aspects of sphingolipid metabolism.
Zeidan YH; Hannun YA
Trends Mol Med; 2007 Aug; 13(8):327-36. PubMed ID: 17588815
[TBL] [Abstract][Full Text] [Related]
9. Regulation of lipid metabolism by sphingolipids.
Worgall TS
Subcell Biochem; 2008; 49():371-85. PubMed ID: 18751919
[TBL] [Abstract][Full Text] [Related]
10. Sphingolipids in cancer: regulation of pathogenesis and therapy.
Ogretmen B
FEBS Lett; 2006 Oct; 580(23):5467-76. PubMed ID: 16970943
[TBL] [Abstract][Full Text] [Related]
11. Ceramide and other sphingolipids in cellular responses.
Yang J; Yu Y; Sun S; Duerksen-Hughes PJ
Cell Biochem Biophys; 2004; 40(3):323-50. PubMed ID: 15211031
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol modulates membrane traffic along the endocytic pathway in sphingolipid-storage diseases.
Puri V; Watanabe R; Dominguez M; Sun X; Wheatley CL; Marks DL; Pagano RE
Nat Cell Biol; 1999 Oct; 1(6):386-8. PubMed ID: 10559968
[No Abstract] [Full Text] [Related]
13. Yeast sphingolipid metabolism: clues and connections.
Sims KJ; Spassieva SD; Voit EO; Obeid LM
Biochem Cell Biol; 2004 Feb; 82(1):45-61. PubMed ID: 15052327
[TBL] [Abstract][Full Text] [Related]
14. Genetic diseases of sphingolipid metabolism: pathological mechanisms and therapeutic options.
Kacher Y; Futerman AH
FEBS Lett; 2006 Oct; 580(23):5510-7. PubMed ID: 16970941
[TBL] [Abstract][Full Text] [Related]
15. The ins and outs of sphingolipid synthesis.
Futerman AH; Riezman H
Trends Cell Biol; 2005 Jun; 15(6):312-8. PubMed ID: 15953549
[TBL] [Abstract][Full Text] [Related]
16. Sphingolipids and cell signalling.
Fredman P
J Inherit Metab Dis; 1998 Aug; 21(5):472-80. PubMed ID: 9728328
[TBL] [Abstract][Full Text] [Related]
17. Sphingolipids in infectious diseases.
Hanada K
Jpn J Infect Dis; 2005 Jun; 58(3):131-48. PubMed ID: 15973004
[TBL] [Abstract][Full Text] [Related]
18. Beyond a structural component: sphingolipids in immunology.
Prieschl EE; Baumruker T
Arch Immunol Ther Exp (Warsz); 2000; 48(3):163-71. PubMed ID: 10912620
[TBL] [Abstract][Full Text] [Related]
19. Concentrations of an activator protein for sphingolipid hydrolysis in liver and brain samples from patients with lysosomal storage diseases.
Inui K; Wenger DA
J Clin Invest; 1983 Nov; 72(5):1622-8. PubMed ID: 6415115
[TBL] [Abstract][Full Text] [Related]
20. Targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy.
Huwiler A; Zangemeister-Wittke U
Crit Rev Oncol Hematol; 2007 Aug; 63(2):150-9. PubMed ID: 17560117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
